Dopamine D2 receptor-mediated modulation of the GABAergic inhibition of substantia nigra pars reticulata neurons

Brain Research

Volumn 729, Issue 2, 1996, Pages 156-169

  Martin, Lynn P ^a   Waszczak, Barbara L ^a  

^a NORTHEASTERN UNIVERSITY   (United States)

Author keywords

D2 dopamine receptor; EEDQ; Extracellular single unit recording; Iontophoresis; Pertussis toxin; Quinpirole; Substantia nigra pars reticulata

Indexed keywords

2 ETHOXY 1(2H) QUINOLINECARBOXYLIC ACID ETHYL ESTER; 4 AMINOBUTYRIC ACID; DOPAMINE 2 RECEPTOR; DOPAMINE 2 RECEPTOR STIMULATING AGENT; EMONAPRIDE; KAINIC ACID; PERTUSSIS TOXIN; QUINPIROLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; INTRACEREBRAL DRUG ADMINISTRATION; IONTOPHORESIS; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SUBSTANTIA NIGRA; ANIMAL; CELL MEMBRANE POTENTIAL; DOSE RESPONSE; DRUG EFFECT; SPRAGUE DAWLEY RAT;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; GAMMA-AMINOBUTYRIC ACID; MALE; MEMBRANE POTENTIALS; QUINPIROLE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D2; SUBSTANTIA NIGRA;

EID: 85047677490     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-8993(96)00226-0     Document Type: Article

References (61)

1. [1] Bach, N.J., Kornfeld, E.C., Jones, N.D., Chaney, M.O., Dorman, D.E., Paschal, J.W., Clemens, J.A. and Smalstig, E.B., Bicyclic and tricyclic ergoline partial structures. Rigid 3-(2-aminoethyl)pyrroles and 3-and 4-(2-aminoethyl)pyrazoles as dopamine agonists, J. Med. Chem., 23 (1980) 481-491.
2. [2] Bean, A.J., Shepard, P.D., Bunney, B.S., Nestler, E.J. and Roth, R.H., The effects of pertussis toxin on autoreceptor-mediated inhibition of dopamine synthesis in the rat striatum, Mol. Pharmacol., 34 (1988) 715-718.
3. 2 receptors with specific cellular elements in the basal ganglia of the cat: The uneven topography of dopamine receptors in the striatum is determined by intrinsic striatal cells, not nigrostriatal axons, Neuroscience, 27 (1988) 851-863.
4. [4] Bjorklund, A. and Lindvall, O., Dopamine in dendrites of substantia nigra neurons: suggestions for a role in dendritic terminals, Brain Res., 83 (1975) 531-537.
5. [5] Brouwer, N., Van Dijken, H., Ruiters, M.H.J., Van Willigen, J.-D. and Ter Horst, G.J. Localization of dopamine D2 receptor mRNA with non-radioactive in situ hybridization histochemisty, Neurosci. Lett., 142 (1992) 223-227.
6. [6] Browning, M.D., Bureau, M., Dudek, E.M. and Olsen, R.W., Protein kinase C and cAMP-dependent protein kinase phosphorylate the β subunit of the purified γ-aminobutyric acid A receptor, Proc. Natl. Acad. Sci. USA, 87 (1990) 1315-1318.
7. [7] Bunney, B.S., Walters, J.R., Roth, R.H. and Aghajanian, G.K., Dopaminergic neurons: Effects of antipsychotic drugs and amphetamine on single cell activity, J. Pharmacol. Exp. Ther., 185 (1973) 560-571.
8. [8] Cameron, D.L. and Crocker, A.D., Localization of striatal dopamine receptor function by central injection of an irreversible receptor antagonist, Neuroscience, 32 (1989) 769-778.
9. [9] Cheramy, A., Leviel, V. and Glowinski, J., Dendritic release of doapmine in the substantia nigra, Nature, 289 (1981) 537-542.
10. [10] Cools, A.R., Jaspers, R., Kolasiewicz, W., Sontag, K-H. and Wolfarth, S., Substantia nigra as a station that not only transmits, but also transforms, incoming signals for its behavioural expression: Striatal dopamine and GABA-mediated responses of pars reticulata neurons, Behav. Brain Res., 7 (1983) 39-49.
11. [11] Cox, R.F. and Waszczak, B.L., Inhibition of substantia nigra dopamine cell firing by R(-)-N-n-propylnorapomorphine: Electrophysiological and autoradiographic studies after regional inactivation of dopamine receptors by microinjection of N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline, Brain Res., 613 (1993) 32-42.
12. [12] Creese, I., Sibley, D.R., Hamblin, M.W. and Leff, S.E., The classification of dopamine receptors: Relationship to radioligand binding, Annu. Rev. Neurosci., 6 (1983) 43-71.
13. [13] Elazar, Z., Siegel, G. and Fuchs, S., Association of two pertussis toxin-sensitive G-proteins with the D2-dopamine receptor from bovine striatum, EMBO J., 8 (1989) 2353-2357.
14. i-protein subunits, Nature, 356 (1992) 159-161.
15. + channels activated by D2 dopamine receptors in acutely dissociated neurons from rat corpus striatum, Proc. Natl. Acad. Sci. USA, 85 (1988) 3618-3622.
16. [16] Gauchy, C., Kemel, M.L., Desban, M., Romo, R., Glowinski, J. and Besson, M.J., The role of dopamine released from distal and proximal dendrites of nigrostriatal dopaminergic neurons in the control of GABA transmission in the thalamic nucleus ventralis medialis in the cat, Neuroscience, 22 (1987) 935-946.
17. [17] Giorgi, O. and Biggio, G., Unilateral inactivation of dopamine receptors after intrastriatal injection of N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ): A novel rotational model to investigate dopamine receptor interactions, Pharmacol. Biochem. Behav., 35 (1990) 877-884.
18. [18] Graybiel, A.M. and Ragsdale, C.W., Fiber connections of the basal ganglia, Prog. Brain Res., 51 (1979) 239-283.
19. [19] Innis, R.B. and Aghajanian, G.K., Pertussis toxin blocks autoreceptor-mediated inhibitions of dopaminergic neurons in rat substantia nigra, Brain Res., 411 (1987) 139-143.
20. B-induced hyperpolarization of rat dorsal raphe neurons, Brain Res., 459 (1988) 27-36.
21. [21] Kanterman, R.Y., Mahan, L.C., Briley, E.M., Monsma, F.J., Sibley, D.R., Axelrod, J. and Felder, C.C., Transfected D2 dopamine receptors mediate the potentiation of arachidonic acid release in chinese hamster ovary cells, Mol. Pharmacol., 36 (1991) 364-369.
22. [22] Katada, T. and Ui, M., Direct modification of the membrane adenylate cyclase systems by islet-activating protein due to ADP-ribosylation of a membrane protein, Proc. Natl. Acad. Sci. USA, 79 (1982) 3129-3133.
23. [23] Konig, J.F.R. and Klippel, R.A., The Rat Brain: a Stereotaxic Atlas, Krieger, Huntington, New York, 1970.
24. [24] Le Boulch, N.L., Truong-Ngoc, N.A. and Gauchy, C., Role of dendritic dopamine of the substantia nigra in the modulation of nigrocollicular g-aminobutyric acid release: In vivo studies in the rat, J. Neurochem., 57 (1991) 1080-1083.
25. A receptor phosphorylation: Multiple sites, actions and artifacts, Trends Pharmacol. Sci., 12 (1991) 84-87.
26. - uptake by brain microsacs, J. Neurochem., 57 (1991) 722-725.
27. [27] Mansour, A., Meador-Woodruff, J.H., Bunzow, J.R., Civelli, O., Akil, H. and Watson, S.J., Localization of dopamine D2 receptor mRNA and D1 and D2 receptor binding in the rat brain and pituitary: An in situ hybridization-receptor autoradiographic analysis, J. Neurosci., 10 (1990) 2587-2600.
28. 1 receptors on striatonigral terminals via a pertussis toxin-sensitive coupling pathway, J. Neurosci., 14 (1994) 4494-4506.
29. A receptor binding and function by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline in vitro and in vivo: Effects of aging, J. Neurochem., 56 (1991) 1241-1247.
30. [30] Milligan, G., Mechanisms of multifunctional signalling by G protein-linked receptors, Trends Pharmacol. Sci., 14 (1993) 239-244.
31. 3H]sulpiride binding in the rat substantia nigra: direct evidence for the existence of nigral D-2 autoreceptors, Eur. J. Pharmacol., 140 (1987) 99-104.
32. A receptors by cAMP-dependent protein phosphorylation, Science, 257 (1992) 661-665.
33. [33] Nieoullon, A., Cheramy, A. and Glowinski, J., Release of dopamine in vivo from cat substantia nigra, Nature, 266 (1977) 375-377.
34. 3H]YM-09151-2, Naunyn-Schmiedeberg's Arch. Pharmacol., 329 (1985) 333-343.
35. [35] Ohara, K., Haga, K., Berstein, G., Haga, T., Ichiyama, A. and Ohara, K., The interaction between D-2 dopamine receptors and GTP-binding proteins, Mol. Pharmacol., 33 (1988) 290-296.
36. [36] Reisine, T., Pertussis toxin in the analysis of receptor mechanisms, Biochem. Pharmacol., 39 (1990) 1499-1504.
37. [37] Richfield, E.K., Young, A.B. and Penney, J.B., Comparative distribution of dopamine D-1 and D-2 receptors in the basal ganglia of turtles, pigeons, rats, cats, and monkeys, J. Comp. Neurol., 262 (1987) 446-463.
38. [38] Robertson, G.S., Damsma, G. and Fibiger, H.C., Characterization of dopamine release in the substantia nigra by in vivo microdialysis in freely moving rats, J. Neurosci., 11 (1991) 2209-2216.
39. [39] Schwartz, R.D. and Yu, X., Inhibition of GABA-gated chloride channel function by arachidonic acid, Brain Res., 585 (1992) 405-410.
40. [40] Sesack, S.R., Aoki, C. and Pickel, V.M., Ultrastructural localization of D2 receptor-like immunoreactivity of midbrain dopamine neurons and their striatal targets, J. Neurosci., 14 (1994) 88-106.
41. A-channels, FEBS Lett., 291 (1991) 150-152.
42. 2-agonists and antagonists on locus coeruleus activity in vivo, Neurosci. Lett., 89 (1988) 361-366.
43. [43] Smith, Y. and Bolam, J.P., Neurons of the substantia nigra reticulata receive a dense GABA-containing input from the globus pallidus in the rat, Brain Res., 493 (1989) 160-167.
44. [44] Smith, Y. and Bolam, J.P., Convergence of synaptic inputs from the striatum and the globus pallidus onto identified nigrocollicular cells in the rat: A retrograde labelling study, Neuroscience, 44 (1991) 45-73.
45. [45] Sokoloff, P., Giros, B., Martres, M.P., Bouthenet, M.L. and Schwartz, J-C., Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics, Nature, 347 (1990) 146-151.
46. [46] Sternweiss, P.C. and Robishaw, J.D., Isolation of two proteins with high affinity for guanine nucleotides from membranes of bovine brain, J. Biol. Chem., 259 (1984) 13806-13813.
47. [47] Tagerud, S.E.O. and Cuello, A.C., Dopamine release from the rat substantia nigra in vitro. Effect of raphe lesions and veratridine stimulation, Neuroscience, 4 (1979) 2021-2029.
48. [48] Tang, W-J. and Gilman, A.G., Type-specific regulation of adenylyl cyclase by G protein βγ subunits, Science, 254 (1991) 1500-1503.
49. i, Neurosci. Lett., 112 (1990) 205-209.
50. A receptor-mediated inhibition of rat substantia nigra dopaminergic neurons by pars reticulata projection neurons, J. Neurosci., 15 (1995) 3092-3103.
51. 3H]raclopride for dopamine D-2 receptor binding to rat striatum, Eur. J. Pharmacol., 173 (1989) 177-182.
52. [52] Terai, M., Usuda, S., Kuroiwa, I., Noshiro, O. and Maeno, H., Selective binding of YM-09151-2, a new potent neurolepic to D2 dopaminergic receptors, Jap. J. Pharmacol., 33 (1983) 749-755.
53. [53] Titus, R.D., Kornfeld, E.C., Jones, N.D., Clemens, J.A., Smalstig, E.B., Fuller, R.W., Hahn, R.A., Hynes, M.D., Mason, N.R., Wong, D.T. and Foreman, M.M., Resolution and absolute configuration of an ergoline-related dopamine agonist, frans-4,4a,5,6,7,8,8a,9-octahydro-5-propyl-1H (or 2H)-pyrazolo[3,4-g]quinoline, J. Med. Chem., 26 (1983) 1112-1116.
54. [54] Vallar, L., Muca, C., Magni, M., Albert, P., Bunzow, J., Meldolesi, J. and Civelli, O., Differential coupling of dopaminergic D2 receptors expressed in different cell types, J. Biol. Chem., 265 (1990) 10320-10326.
55. [55] Van Der Kooy, D. and Hattori, T., Dorsal raphe cells with collateral projections to the caudate-putamen and substantia nigra: A fluorescent retrograde double labeling study in the rat, Brain Res., 186 (1980) 1-7.
56. [56] Waszczak, B.L., Differential effects of D1 and D2 dopamine receptor agonists on substantia nigra pars reticulata neurons, Brain Res., 513 (1990) 125-135.
57. [57] Waszczak, B.L., Eng, N. and Walters, J.R., Effects of muscimol and picrotoxin on single unit activity of substantia nigra neurons, Brain Res., 188 (1980) 185-197.
58. [58] Waszczak, B.L. and Walters, J.R., Dopamine modulation of the effects of γ-aminobutyric acid on substania nigra pars reticulata neurons, Science, 220 (1983) 218-221.
59. [59] Waszczak, B.L. and Walters, J.R., A physiological role for dopamine as modulator of GABA effects in substantia nigra: Supersensitivity in 6-hydroxydopamine-lesioned rats, Eur. J. Pharmacol., 105 (1984) 369-373.
60. [60] Waszczak, B.L. and Walters, J.R., Endogenous dopamine can modulate inhibition of substantia nigra pars reticulata neurons elicited by GABA iontophoresis or striatal stimulation, J. Neurosci., 6 (1986) 120-126.
61. [61] Weiner, D.M. and Brann, M.R., The distribution of a dopamine D2 receptor mRNA in rat brain, FEBS Lett., 253 (1989) 207-213.